3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Genitourinary
1
Breast
1
Conditions
Anxiety Disorders
2
Testicular Germ Cell Tumor
1
Sarcoma
1
Ovarian Neoplasms
1
Leukemia, Myeloid, Acute
1
Depression
1
Breast Neoplasms
1
Interventions
Paclitaxel
9
Carboplatin
8
Bevacizumab
8
fluzoparib
5
olaparib
3
Topotecan
3
Gemcitabine
3
liposomal doxorubicin
2
famitinib
2
apatinib
2
Oxaliplatin
2
Magnetic Resonance Spectroscopy
2
Indocyanine Green
2
Drug Therapy
2
Cisplatin
2
trametinib
1
senaparib
1
pembrolizumab
1
niraparib
1
montelukast
1
irinotecan sucrosofate
1
fludarabine
1
durvalumab
1
dalpiciclib
1
dabrafenib
1
ceralasertib
1
anlotinib
1
aldesleukin
1
Ultrasonography, Doppler
1
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Ovarian Neoplasms
×
Hypnosis
×
Clear all
NCT07614620
2026-05-29
HYPNO-AJA2
Institut Bergonié
Phase NA
Not yet recruiting
70 enrolled